000 02278 a2200613 4500
005 20250514191356.0
264 0 _c20050210
008 200502s 0 0 eng d
022 _a1524-4636
024 7 _a10.1161/01.ATV.0000134299.89599.53
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWallner, Kurt
245 0 0 _aEGF-Like domain of tenascin-C is proapoptotic for cultured smooth muscle cells.
_h[electronic resource]
260 _bArteriosclerosis, thrombosis, and vascular biology
_cAug 2004
300 _a1416-21 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAmino Acid Chloromethyl Ketones
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCarotid Arteries
_xchemistry
650 0 4 _aCaspase 3
650 0 4 _aCaspase Inhibitors
650 0 4 _aCaspases
_xmetabolism
650 0 4 _aCell Line
650 0 4 _aCricetinae
650 0 4 _aCysteine Proteinase Inhibitors
_xpharmacology
650 0 4 _aDactinomycin
_xpharmacology
650 0 4 _aDipeptides
_xpharmacology
650 0 4 _aEnzyme Activation
_xdrug effects
650 0 4 _aEnzyme Induction
_xdrug effects
650 0 4 _aEpidermal Growth Factor
_xchemistry
650 0 4 _aHumans
650 0 4 _aMatrix Metalloproteinase Inhibitors
650 0 4 _aMatrix Metalloproteinases
_xbiosynthesis
650 0 4 _aMesocricetus
650 0 4 _aMuscle, Smooth, Vascular
_xcytology
650 0 4 _aMyocytes, Smooth Muscle
_xcytology
650 0 4 _aOligopeptides
_xpharmacology
650 0 4 _aPeptide Fragments
_xchemistry
650 0 4 _aProtease Inhibitors
_xpharmacology
650 0 4 _aProtein Isoforms
_xchemistry
650 0 4 _aProtein Structure, Tertiary
650 0 4 _aRats
650 0 4 _aRecombinant Fusion Proteins
_xpharmacology
650 0 4 _aStaurosporine
_xpharmacology
650 0 4 _aTenascin
_xchemistry
700 1 _aLi, Chen
700 1 _aShah, Prediman K
700 1 _aWu, Kai-Jin
700 1 _aSchwartz, Stephen M
700 1 _aSharifi, Behrooz G
773 0 _tArteriosclerosis, thrombosis, and vascular biology
_gvol. 24
_gno. 8
_gp. 1416-21
856 4 0 _uhttps://doi.org/10.1161/01.ATV.0000134299.89599.53
_zAvailable from publisher's website
999 _c14886091
_d14886091